Cancer researchers will benefit from fees raised by a healthcare investment fund to be launched this week.
Schroder Unit Trusts says it will donate half the initial fees raised and then make annual donations worth 0.25 per cent of the fund's value to the Cancer Research Campaign.
The Medical Discovery Fund will invest for long term growth in pharmaceuticals, medical technology, healthcare services and biotechnology stocks. The initial fee is 3.25 per cent until June 9.
Cancer Research Campaign director-general Gordon McVie says: “I am delighted that the campaign is to benefit from contributions Schroders will make as a result of the Medical Discovery Fund.”